Compound Q&A
What is the market or research trend for Bupivacaine (CAS: 2180-92-9)?
Answer
Bupivacaine (CAS: 2180-92-9) remains a significant player in the local anesthetic market due to its broad clinical use. Research trends focus on optimizing its use in regional and epidural anesthesia. Emerging studies aim to reduce potential side effects and improve the drug's efficiency. Market trends show a steady demand, with a focus on reducing healthcare costs and enhancing patient outcomes.
About
CAS No
2180-92-9
English Name
Bupivacaine
Molecular Formula
C18H28N2O
Molecular Weight
288.4 g/mol
SMILES
CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
InChIKey
LEBVLXFERQHONN-UHFFFAOYSA-N
Last Updated: 2025-09-21 10:38
